Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Uhlman

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Medical Oncology|July 27, 2011
Risk stratification in the hormonal treatment of patients with prostate cancerMatthew A Uhlman, Judd W Moul, Ping Tang, et al.
Current Urology|June 12, 2014
Novel Use of AngioVac System to Prevent Pulmonary Embolism during Radical Nephrectomy with Inferior Vena Cava ThrombectomyRobert J Brown, Matthew A Uhlman, Joss D Fernandez, et al.
Urology|December 4, 2013
Improving access to urologic care for rural populations through outreach clinicsMatthew A Uhlman, Thomas S Gruca, Roger Tracy, et al.
Urology|January 21, 2014
Variations in the open market costs for prostate cancer surgery: a survey of US hospitalsScott C Pate, Matthew A Uhlman, Jaime A Rosenthal, et al.
The Canadian Journal of Urology|August 22, 2016
Bladder cancer will grow anywhere: report of a urothelial carcinoma drop metastasis to the vagina and literature reviewMatthew A Uhlman, Mark D Bevill, Michael J Goodheart, et al.
BJU International|November 6, 2010
Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly menPing Tang, Leon Sun, Matthew A Uhlman, et al.
Cancer|July 1, 2010
Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experiencePing Tang, Leon Sun, Matthew A Uhlman, et al.
The Journal of Urology|January 20, 2010
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer riskPing Tang, Leon Sun, Matthew A Uhlman, et al.
Urology|December 29, 2009
Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American menPing Tang, Leon Sun, Matthew A Uhlman, et al.
The Journal of Urology|January 22, 2010
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostateMatthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Medical Oncology|July 27, 2011
Risk stratification in the hormonal treatment of patients with prostate cancerMatthew A Uhlman, Judd W Moul, Ping Tang, et al.
Current Urology|June 12, 2014
Novel Use of AngioVac System to Prevent Pulmonary Embolism during Radical Nephrectomy with Inferior Vena Cava ThrombectomyRobert J Brown, Matthew A Uhlman, Joss D Fernandez, et al.
Urology|December 4, 2013
Improving access to urologic care for rural populations through outreach clinicsMatthew A Uhlman, Thomas S Gruca, Roger Tracy, et al.
Urology|January 21, 2014
Variations in the open market costs for prostate cancer surgery: a survey of US hospitalsScott C Pate, Matthew A Uhlman, Jaime A Rosenthal, et al.
The Canadian Journal of Urology|August 22, 2016
Bladder cancer will grow anywhere: report of a urothelial carcinoma drop metastasis to the vagina and literature reviewMatthew A Uhlman, Mark D Bevill, Michael J Goodheart, et al.
BJU International|November 6, 2010
Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly menPing Tang, Leon Sun, Matthew A Uhlman, et al.
Cancer|July 1, 2010
Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experiencePing Tang, Leon Sun, Matthew A Uhlman, et al.
The Journal of Urology|January 20, 2010
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer riskPing Tang, Leon Sun, Matthew A Uhlman, et al.
Urology|December 29, 2009
Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American menPing Tang, Leon Sun, Matthew A Uhlman, et al.
The Journal of Urology|January 22, 2010
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostateMatthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Pageof 3